| Catalog | name | Description | price |
|---|---|---|---|
| R-R-4084 | Olorinab CAS No.1268881-20-4 | Olorinab (APD 371)/CAS No.1268881-20-4 is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist, with an EC50 of 6.2 nM for hCB2. | price> |
| R-R-4085 | Yangonin CAS No.500-62-9 | Yangonin/CAS No.500-62-9 exhibits affinity for the human recombinant cannabinoid CB1 receptor with an IC50 and a Ki of 1.79 μM and 0.72 μM, respectively. | price> |
| R-R-4086 | AM281 CAS No.202463-68-1 | AM281/CAS No.202463-68-1 is a selective CB1 receptor antagonist with an IC50 of 9.91 nM. AM281 inhibits CB2 receptor with an IC50 of 13000 nM. | price> |
| R-R-4087 | LY2828360 CAS No.1231220-79-3 | LY2828360/CAS No.1231220-79-3 is a slowly acting but efficacious G protein-biased cannabinoid (CB2) agonist, inhibiting cAMP accumulation and activating ERK1/2 signaling. | price> |
| R-R-4088 | Monlunabant CAS No.2712480-46-9 | Monlunabant ((S)-MRI-1891)/CAS No.2712480-46-9 is a solid dispersions compound, as well as a cannabinoid CB1 receptor inhibitor. | price> |
| R-R-4089 | (±)-Ibipinabant CAS No.362519-49-1 | (±)-Ibipinabant ((±)-SLV319)/CAS No.362519-49-1 is the racemate of SLV319. (±)-Ibipinabant ((±)-SLV319) is a potent and selective cannabinoid-1 (CB-1) receptor antagonist with an IC50 of 22 nM. | price> |
| R-R-4090 | CB1 antagonist 4 CAS No.1253641-65-4 | CB1 antagonist 4 (compound 8)/CAS No.1253641-65-4 is a peripheral selective cannabinoid receptor type 1 (CB1) receptor antagonist. CB1 antagonist 4 shows limited penetrance to the brain in order to minimize or prevent CNS adverse reactions, and preserves potential antiobesity effects. CB1 antagonist 4 reduces propensity for psychiatric side effects. | price> |
| R-R-4091 | Org 27569 CAS No.868273-06-7 | Org 27569/CAS No.868273-06-7 is a potent CB1 receptor allosteric modulator, which increases agonist binding, yet blocks agonist-induced CB1 signaling. | price> |
| R-R-4092 | GW-405833 CAS No.180002-83-9 | GW-405833 (L768242)/CAS No.180002-83-9 is a potent, selective cannabinoid receptor 2 (CB2) agonist with an EC50 of 50.7 nM. GW-405833 also behaves as a noncompetitive CB1 antagonist. GW-405833 suppresses inflammatory and neuropathic pain. | price> |
| R-R-4093 | Leelamine hydrochloride CAS No.16496-99-4 | Leelamine hydrochloride/CAS No.16496-99-4 is a tricyclic diterpene molecule that is extracted from the bark of pine trees. Leelamine hydrochloride is a cannabinoid receptor type 1 (CB1) agonist and a inhibitor of SREBP1-regulated fatty acid/lipid synthesis in prostate cancer cells that is not affected by androgen receptor status. Leelamine hydrochloride suppresses transcriptional activity of androgen receptor, which is known to regulate fatty acid synthesis[2,3]. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


